Cognitive deficits in multiple sclerosis: Correlations with T2 changes in normal appearing brain tissue

Acta Neurologica Scandinavica

Volumn 125, Issue 5, 2012, Pages 338-344

  Lund, H ^a   Jonsson A ^b   Andresen, J ^c   Rostrup, E ^a   Paulson, O B ^a   Sorensen P S ^b  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c Danish Psychological Publishers   (Denmark)

Author keywords

Cognitive impairment; Magnetic resonance imaging; Multiple sclerosis; T2 estimates

Indexed keywords

ADULT; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMAGE PROCESSING; INTELLIGENCE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROBLEM SOLVING; RETROSPECTIVE STUDY; VOXEL BASED MORPHOMETRY;

ADULT; BRAIN; COGNITION DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; RETROSPECTIVE STUDIES;

EID: 84859430836     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01574.x     Document Type: Article

References (36)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-91.
2. Comi G, Filippi M, Martinelli Vet al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-7.
3. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003;16:283-8.
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-39.
5. Lassmann H. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am 2008;18:563-76. ix.
6. McDonald WI, Compston A, Edan Get al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
7. Comi G, Rovaris M, Falautano Met al.A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. J Neurol Sci 1999;171:135-44.
8. Filippi M, Tortorella C, Rovaris Met al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157-61.
9. Zivadinov R, De Masi R, Nasuelli Det al. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001;43:272-8.
10. Sarchielli P, Presciutti O, Pelliccioli GPet al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 1999;122(Pt 3):513-21.
11. Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304-11.
12. Rovaris M, Filippi M, Falautano Met al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-8.
13. Denney DR, Lynch SG, Parmenter BA, Horne N. Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed. J Int Neuropsychol Soc 2004;10:948-56.
14. Schulz D, Kopp B, Kunkel A, Faiss JH. Cognition in the early stage of multiple sclerosis. J Neurol 2006;253:1002-10.
15. Poser CM, Paty DW, Scheinberg Let al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
16. Mathiesen HK, Jonsson A, Tscherning Tet al. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis. Arch Neurol 2006;63:533-6.
17. Perona P, Malik J. Scale-space and edge-detection using anisotropic diffusion. IEEE Trans Pattern Anal Mach Intell 1990;12:629-39.
18. Feinstein A. The Clinical Neuropsychiatry of Multiple Sclerosis. Cambridge, UK: Cambridge University Press, 1999.
19. Reuter F, Del Cul A, Audoin Bet al. Intact subliminal processing and delayed conscious access in multiple sclerosis. Neuropsychologia 2007;45:2683-91.
20. Ravnborg M, Blinkenberg M, Sellebjerg F, Ballegaard M, Larsen SH, Sorensen PS. Responsiveness of the multiple sclerosis impairment scale in comparison with the expanded disability status scale. Mult Scler 2005;11:81-4.
21. Zivadinov R, Sepcic J, Nasuelli Det al.A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773-80.
22. Fulton JC, Grossman RI, Udupa Jet al.MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 1999;20:1951-5.
23. Sperling RA, Guttmann CR, Hohol MJet al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001;58:115-21.
24. Vrenken H, Rombouts SA, Pouwels PJ, Barkhof F. Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. AJNR Am J Neuroradiol 2006;27:868-74.
25. Tekok-Kilic A, Benedict RH, Weinstock-Guttman Bet al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007;36:1294-300.
26. Inglese M, Park SJ, Johnson Get al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007;64:196-202.
27. Callanan MM, Logsdail SJ, Ron MA, Warrington EK. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain 1989;112(Pt 2):361-74.
28. Charil A, Zijdenbos AP, Taylor Jet al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003;19:532-44.
29. Narayanan S, Fu L, Pioro Eet al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-91.
30. Lee MA, Smith S, Palace Jet al. Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?. Brain 1999;122(Pt 7):1261-70.
31. Sepulcre J, Masdeu JC, Pastor MAet al. Brain pathways of verbal working memory: a lesion-function correlation study. Neuroimage 2009;47:773-8.
32. Amato MP, Bartolozzi ML, Zipoli Vet al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004;63:89-93.
33. Akbar N, Lobaugh NJ, O'Connor P, Moradzadeh L, Scott CJM, Feinstein A. Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients. Can J Neurol Sci 2010;37:608-14.
34. Van Waesberghe JH, Kamphorst W, De Groot CJet al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-54.
35. Van Buchem MA, Grossman RI, Armstrong Cet al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-17.
36. Salthouse TA, Schroeder DH, Ferrer E. Estimating retest effects in longitudinal assessments of cognitive functioning in adults between 18 and 60years of age. Dev Psychol 2004;40:813-22.